AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0

Eribilin Injection

Prescription Icon
Prescription Required

Marketer

Emcure Pharmaceuticals Ltd

Salt Composition

Eribulin Mesylate (1mg)

Overview Eribilin Injection

Halaven Injection is indicated for treating metastatic breast cancer in adults. It's administered after other anticancer therapies have been used, following the cancer's progression. Halaven may be used alone or in combination with other medications as part of a chemotherapy regimen. Administered intravenously under medical supervision, dosage and frequency are determined by your physician based on your condition and may vary. Strict adherence to the prescribed regimen is crucial; incorrect usage or overdose can lead to severe adverse effects. Therapeutic benefits may not be immediately apparent, potentially taking weeks or months; discontinuation should only occur under medical guidance. Common side effects include fatigue, alopecia, nausea, and bowel irregularity. Halaven can decrease blood cell counts, increasing infection risk, necessitating regular blood tests to monitor blood cell levels, cardiac function, liver health, uric acid, and electrolytes. Peripheral neuropathy, manifesting as numbness, tingling, or pins and needles in the extremities, may occur; prompt medical attention is warranted if persistent or bothersome. Prior to initiation, disclose any pre-existing heart, liver, or kidney conditions, as well as any medications, particularly those for infections. Numerous drug interactions are possible; inform your physician of all current medications. Halaven is contraindicated during pregnancy and breastfeeding; effective contraception is essential for both partners throughout treatment.

Uses of Eribilin Injection

Breast cancer with distant spread

Major Benefits of Eribilin Injection:

Your healthcare provider will instruct you on the proper administration of this medication.

Common Side effects of Eribilin Injection:

  • Anemia (low number of red blood cells)
  • Weakness
  • Hair loss
  • Nausea
  • Constipation
  • Decreased white blood cell count
  • Fatigue
  • Peripheral neuropathy (tingling and numbness of feet and hand)

How to use Eribilin Injection:

Medical professionals will instruct you on the proper administration of this medication.

How Eribilin Injection works:

Eribulin injection is a cancer treatment that disrupts the microtubules essential for cancer cell division and proliferation. This disruption halts the cancer cells' growth cycle, leading to their demise.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Eribilin Injection has an unknown safety profile. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Eribilin Injection during pregnancy is contraindicated due to confirmed risk to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.

Breast feedingBreast feedingUNSAFE

Use of Eribilin Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingUNSAFE

Eribilin Injection can cause drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects are experienced.

KidneyKidneyCAUTION

Individuals with impaired kidney function should use Eribilin Injection with close monitoring. Dosage modification may be necessary. Physician consultation is recommended.

LiverLiverCAUTION

Patients with hepatic impairment should receive Eribilin Injection with careful monitoring. Dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Eribilin Injection :

NA

Facts to Know About Eribilin Injection

LabelValue
Chemical Type Halichondrin B analog
Developing Habits No.
Type of Therapy Cancer Therapeutics
Actions Non-Taxane Microtubule Inhibitors

FAQs on Eribilin Injection

Eribilin Injection may cause hair loss, a side effect that can be reversible but varies in severity. Discuss any concerns about hair loss with your doctor.
Eribilin injections are typically administered on days 1 and 8 of each 21-day treatment cycle. Treatment length varies individually, with the total number of cycles determined by your doctor. Treatment may be delayed, or the dosage adjusted, based on your blood test results.
A doctor or healthcare professional will administer Eribilin Injection intravenously over 2 to 5 minutes. Dosage, determined by your body surface area (m²), calculated from your weight and height, may be adjusted based on your blood test results and other individual factors. Following Eribilin Injection, a saline flush is recommended to ensure complete delivery.
Eribilin Injection carries serious risks, including a dangerously low white blood cell count (neutropenia), potentially causing fatal infections. Numbness, tingling, or pain in the hands or feet (peripheral neuropathy) is also possible; this common side effect can be severe. Use during pregnancy may harm the baby.
Women of childbearing age must use effective contraception for three months following Eribilin Injection treatment. Eribilin Injection may cause serious birth defects and should not be used during pregnancy unless absolutely necessary after careful consideration of the risks to both mother and child.
Handle Eribilin Injection with care, avoiding contact with skin, eyes, mouth, or nose. Wear gloves, goggles, and protective clothing. In case of skin contact, wash thoroughly with soap and water. If contact occurs with eyes, mouth, or nose, flush the area thoroughly with water. Pregnant personnel should not handle this medication.
Eribilin Injection should be diluted with up to 100 ml of 0.9% sodium chloride solution (not 5% dextrose) and administered only by a healthcare professional under the supervision of a physician experienced in cancer chemotherapy.
Eribilin Injection
16,848
MRP 19,500
13% off